Publication: Tyrosine kinase/phosphatase inhibitors decrease dengue virus production in HepG2 cells
Issued Date
2017-01-29
Resource Type
ISSN
10902104
0006291X
0006291X
Other identifier(s)
2-s2.0-85009266728
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biochemical and Biophysical Research Communications. Vol.483, No.1 (2017), 58-63
Suggested Citation
Thawornchai Limjindaporn, Jutatip Panaampon, Shilu Malakar, Sansanee Noisakran, Pa thai Yenchitsomanus Tyrosine kinase/phosphatase inhibitors decrease dengue virus production in HepG2 cells. Biochemical and Biophysical Research Communications. Vol.483, No.1 (2017), 58-63. doi:10.1016/j.bbrc.2017.01.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/41973
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Tyrosine kinase/phosphatase inhibitors decrease dengue virus production in HepG2 cells
Other Contributor(s)
Abstract
© 2017 Elsevier Inc. Dengue virus is the causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. High rates of dengue virus replication and virion production are related to disease severity. To identify anti-DENV compounds, we performed cell-based ELISA testing to detect the level of DENV E protein expression. Among a total of 83 inhibitors, eight were identified as inhibitors with antiviral activity. Epidermal growth factor receptor inhibitor II (EGFR/ErbB-2/ErbB-4 inhibitor II) and protein tyrosine phosphatase inhibitor IV (PTP inhibitor IV) significantly inhibited dengue virus production and demonstrated low toxicity in hepatocyte cell lines. Our results suggest the efficacy of tyrosine kinase/phosphatase inhibitors in decreasing dengue virus production in HepG2 cells.